The Cooper Companies, Inc. $COO Stock: Sumitomo Mitsui DS Asset Management Company Ltd Boosts Stake

Key Points

• Sumitomo Mitsui DS Asset Management increased its Cooper Companies stake by 84% in the third quarter, bringing its holdings to 52,747 shares valued at approximately $2.98 million. Institutional investors collectively own 24.39% of COO.
• Analysts maintain a generally cautious outlook, with an average rating of “Hold” and an average price target of $68.60. COO recently traded at $61.65, while targets from several firms were reduced.
• Cooper Companies reported quarterly EPS of $1.15, exceeding estimates, and authorized a $3 billion share buyback covering up to 22.7% of outstanding shares. Directors also purchased shares, with insiders buying 34,701 shares worth about $1.88 million over the past 90 days.

Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 84.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 52,747 shares of the medical device company's stock after buying an additional 24,084 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Cooper Companies were worth $2,982,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in COO. Avalon Trust Co purchased a new position in Cooper Companies in the second quarter worth about $25,000. SJS Investment Consulting Inc. increased its stake in Cooper Companies by 107.5% during the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company's stock worth $26,000 after acquiring an additional 187 shares during the last quarter. Elevation Wealth Partners LLC increased its stake in Cooper Companies by 1,136.4% during the second quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company's stock worth $29,000 after acquiring an additional 375 shares during the last quarter. Continuum Advisory LLC bought a new stake in Cooper Companies during the second quarter worth approximately $30,000. Finally, J.Safra Asset Management Corp purchased a new stake in Cooper Companies during the second quarter valued at approximately $32,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on COO shares. Robert W. Baird set a $61.00 price objective on Cooper Companies and gave the company a "neutral" rating in a research note on Thursday, September 10th. Piper Sandler reissued a "neutral" rating on shares of Cooper Companies in a research report on Thursday, October 15th. Citigroup reissued a "neutral" rating and set a $60.00 target price (down from $80.00) on shares of Cooper Companies in a research report on Thursday, September 10th. Needham & Company LLC decreased their price target on Cooper Companies from $86.00 to $73.00 and set a "buy" rating on the stock in a report on Thursday, September 10th. Finally, JPMorgan Chase & Co. lowered their price target on Cooper Companies from $71.00 to $58.00 and set a "neutral" rating for the company in a research report on Thursday, September 10th. Four investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $68.60.

Cooper Companies Price Performance

COO stock opened at $61.65 on Friday. The Cooper Companies, Inc. has a 12 month low of $51.01 and a 12 month high of $89.83. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The company has a 50-day moving average price of $62.09 and a 200 day moving average price of $65.80. The stock has a market cap of $11.72 billion, a PE ratio of 21.04, a P/E/G ratio of 2.40 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the prior year, the firm posted $0.49 EPS. The firm's revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies declared that its board has initiated a share buyback plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in outstanding shares. This buyback authorization allows the medical device company to buy up to 22.7% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's board of directors believes its shares are undervalued.

Insiders Place Their Bets

In other Cooper Companies news, Director Lawrence Kurzius bought 10,000 shares of the business's stock in a transaction dated Wednesday, September 16th. The shares were purchased at an average price of $54.93 per share, with a total value of $549,300.00. Following the completion of the purchase, the director owned 31,099 shares in the company, valued at $1,708,268.07. This represents a 47.40% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Walter M. Rosebrough, Jr. purchased 3,000 shares of Cooper Companies stock in a transaction dated Monday, September 14th. The stock was acquired at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the completion of the acquisition, the director owned 20,000 shares of the company's stock, valued at approximately $1,085,800. This trade represents a 17.65% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 34,701 shares of company stock valued at $1,880,039 over the last 90 days. Insiders own 2.08% of the company's stock.

Cooper Companies Company Profile

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women's health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women's health.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.